Oncogenic NOVA1 expression dysregulates alternative splicing in breast cancer
Moakley, D. F.; Zhang, C.
Show abstract
Neuro-Oncological Ventral Antigen 1 (NOVA1) is best known for its role in mediating an alternative splicing (AS) program in neurons, yet was first discovered as an antigen expressed in breast tumors, causing rare autoimmune reactions and paraneoplastic neurological disorders (PNDs). The PND model suggests a plausible role of the tumor antigen expression in tumor suppression, whereas it has emerged that NOVA may function as an oncogene in a variety of cancers. In addition, whether NOVA mediates AS in breast cancer remains unanswered. Here we examine the AS profiles of breast invasive carcinoma (BRCA) tumor samples and demonstrate that ectopic NOVA1 expression led to the activation of neuron-like splicing patterns in many genes, including exons targeted by NOVA in the brain. The splicing dysregulation is especially prevalent in cell periphery and cytoskeleton genes related to cell-cell communication, actin-based movement, and neuronal functions. We find that NOVA1-mediated AS is most prominent in Luminal A tumors and high NOVA1 expression in this subtype is associated with poorer prognosis. Our results suggest that ectopic NOVA1 in tumors has regulatory activity affecting pathways with high relevance to tumor progression and that this might be a more general mechanism for PND antigens.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription 96%
- The ALT pathway generates telomere fusions that can be detected in the blood of cancer patients 96%
- Guardian ubiquitin E3 ligases target cancer-associated APOBEC3 deaminases for degradation to promote human genome integrity. 96%
Similar papers in this journal
- Evolution of chromosome arm aberrations in breast cancer through genetic network rewiring 97%
- RNA Splicing Junction Landscape Reveals Abundant Tumor-Specific Transcripts in Human Cancer 96%
- Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors 96%
Similar papers in this journal
Similar papers in this journal
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 96%
- Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses 95%
- Single cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells 95%
Similar papers in this journal
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 96%
- A sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression 96%
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.